Cynthia Frankel, RN | Authors

University of Miami

38030 DAUGHTERY RD

Pembroke Pines

33028

Articles

Rationale for Trials Studying Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer

October 01, 1997

Breast cancer is second only to lung cancer as a leading cause of cancer mortality in women. In women with metastatic, hence, essentially incurable disease, we strive to find effective chemotherapeutic regimens that offer a